Axxess Pharma Inc. President, Daniel Bagi, M.D. Provides Exclusive Interview on StockTradersTalk.com
12 September 2013 - 10:00PM
Marketwired
Axxess Pharma Inc -- (PINKSHEETS: AXXE) a specialty pharmaceutical
and nutritional supplements company -- is pleased to announce its
President, Daniel Bagi, M.D. was featured as a guest in an
exclusive interview on Wednesday September 11, 2013.
This interview discussed pending acquisitions, license deals,
new additions to management, and plans for growth.
To listen to the full interview, please click on the following
link: http://www.stocktraderstalk.com/
About StockTradersTalk:
StockTradersTalk specializes in radio
interviews, and believes that when a CEO has the ability to
demonstrate their passion, and personally cover talking points for
their company it serves as the ultimate delivery platform. Press
Releases have value, however, they lack the effectiveness of a
webcast in helping a CEO connect with both current and potential
shareholders on a personal level.
Stock Traders Talk Radio is an uncensored, comprehensive
approach to disseminating vital facts about public companies
trading on the OTC Markets.
About Axxess Pharma Inc.:
Axxess Pharma Inc. is a Nevada Corporation operating through its
wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc.,
headquartered in Toronto. Axxess is a specialty Health Care
Products Company dedicated to improving health and quality of life
by offering select medicines, nutritional supplements and over the
counter remedies all across the Americas. Axxess's goal is to bring
additional products to the market and provide new, innovative
options for better health spanning areas such as high cholesterol,
blood pressure, acute pain, -- to optimal health management through
improved nutritional supplements.
Safe Harbor Statement:
Statements about the Company's future expectations and all other
statements in this press release other than historical facts, are
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as that term is defined in the Private Securities
Litigation Reform Act of 1995. The Company intends that such
forward-looking statements be subject to the safe harbors created
thereby.
The above information contains information relating to the
Company that is based on the beliefs of the Company and/or its
management, as well as assumptions made by any information
currently available to the Company or its management. When used in
this document, the words "anticipate," "estimate," "expect,"
"intend," "plans," "projects," and similar expressions, as they
relate to the Company or its management, are intended to identify
forward-looking statements. Such statements reflect the current
view of the Company regarding future events and are subject to
certain risks, uncertainties and assumptions, including the risks
and uncertainties noted. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
to be incorrect, actual results may vary materially from those
described herein as anticipated, believed, estimated, expected,
intended or projected. In each instance, forward-looking
information should be considered in light of the accompanying
meaningful cautionary statements herein. Factors that could cause
results to differ include, but are not limited to, successful
performance of internal plans, the impact of competitive services
and pricing and general economic risks and uncertainties.
Contact: Investor Relations Taylor Capitol, Inc. Stephen Taylor
(973) 351-3868 Stock Traders Talk Peter J. Nicosia Director
of Marketing Tel#: 561-228-1692 www.stocktraderstalk.com
stocksumo@stocktraderstalk.com
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Jun 2024 to Jul 2024
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Jul 2023 to Jul 2024